Targeted therapies in hematologic malignancies

Veröffentlicht 2004

Targeted therapies in hematologic malignancies

Veröffentlicht 2004

Proteasome inhibition: a new pathway in cancer therapy : [based on the proceedings of the recent Symposium Proteasome Inhibition: A New Pathway in Cancer Therapy held December 6,...

Veröffentlicht 2003

Proteasome inhibition in hematologic malignancies: clinical update and practical applications : presentations from the 8th Annual "Making a Difference in Oncology" Conference, St...

Veröffentlicht 2004

UNLOCKING THE POTENTIAL OF REAL-WORLD EVIDENCE (RWE) IN ONCOLOGY - TECHNOLOGY- AND INFORMATICS-ENABLED SOLUTIONS FOR CLINICAL CARE, PRECISION MEDICINE, AND DISCOVERY

von Miller, Robert S.
Veröffentlicht in AMIA Annual Symposium (2019 : Washington, DC) American Medical Informatics Association Annual Symposium (AMIA 2019) ; Volume 1 of 3 (2020)

Dexverapamil - a clinical approach to circumvention of multidrug resistance : satellite symposium to the 1st International Conference on Reversal of Multidrug Resistance in Cance...

Veröffentlicht 1995

Dexverapamil : a clinical approach to circumvention of multidrug resistance ; satellite symposium to the 1st International Conference on Reversal of Multidrug Resistance in Cance...

Veröffentlicht 1995

Dexverapamil: a clinical approach to circumvention of multidrug resistance

Veröffentlicht 1995